내용 바로 가기

정형외과

경제적 효과

Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). (새로운 창 열기)

Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA.

Source‎: Transfusion 2008;48(2):237-50.

Indexed‎: PubMed 18005329

DOI‎: 10.1111/j.1537-2995.2007.01515.x

https://www.ncbi.nlm.nih.gov/pubmed/18005329 (새로운 창 열기)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (새로운 창 열기)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Source‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indexed‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (새로운 창 열기)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (새로운 창 열기)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Source‎: Int Orthop 2019;43(12):2707-14.

Indexed‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (새로운 창 열기)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (새로운 창 열기)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Source‎: J Arthroplasty 2014;29(8):1512-5.

Indexed‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (새로운 창 열기)